Full Text
Cost-Effectiveness Analysis Of Cetuximab And Panitumumab For First Line Treatment Of Metastatic Colorectal Cancer (Mcrc) In Wt Ras Patients In Spain

Abstract

Authors

J Suarez

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×